Targeted Radiotherapy for Neuroblastoma with MIBG
Join us for a Webinar on April 7
Space is limited.
Reserve your Webinar seat now at:
https://www2.gotomeeting.com/register/202269403
Dr. Kate Matthay, New Approaches to Neuroblastoma Therapy (NANT) Consortium leader and pediatric oncologist from the University of California - San Francisco (UCSF) presents part 2 of the ongoing NANT clinical trial series.  This presentation is appropriate for parents of children with neuroblastoma, caregivers, and health care professionals.  Dr. Matthay will be presenting the latest information concerning the use of MIBG in neuroblastoma therapy.  She will discuss previous clinical research in MIBG and what is currently available to patients through clinical trials.  You can expect to leave this meeting with a thorough understanding of MIBG treatment in neuroblastoma, the eligibility requirements, and what is currently being offered.
Title:   Targeted Radiotherapy for Neuroblastoma with MIBG
Date: Wednesday, April 7, 2010
Time: 10:00 AM - 11:00 AM PDT
After registering you will receive a confirmation email containing information about joining the Webinar.
System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based attendees
Required: Mac OS® X 10.4.11 (Tiger®) or newer
Posted 2 Apr 2010 3:05 AM by Mark Dungan
Filed under: , , , ,

Comments

Becky Lambert wrote re: Targeted Radiotherapy for Neuroblastoma with MIBG
on 6 Apr 2010 8:32 PM

Is there any way to view this after the 10am-11am showing?  We will be at the oncology clinic at that time.  

Thank you if that is possible.

Mark Dungan wrote re: Targeted Radiotherapy for Neuroblastoma with MIBG
on 7 Apr 2010 4:56 AM

Becky,

Yes, the seminar will be recorded and posted here on the website within a week of the live seminar.

janfazju wrote re: Targeted Radiotherapy for Neuroblastoma with MIBG
on 19 May 2010 8:23 AM

DNlFMV  <a href="ywyezxjgslto.com/.../a>, [url=http://gedpnhnuseqg.com/]gedpnhnuseqg[/url], [link=http://fedqkoouftaz.com/]fedqkoouftaz[/link], http://mkqnnrjbqlem.com/

http://izmvzeuqnzfr.com/ wrote re: Targeted Radiotherapy for Neuroblastoma with MIBG
on 21 Jun 2010 7:42 PM

sPBCfn  <a href="sjtsbuccvuom.com/.../a>, [url=http://scppuicjwwgo.com/]scppuicjwwgo[/url], [link=http://fuakisopnbsc.com/]fuakisopnbsc[/link], http://mdguuheglwqb.com/

zgrnfmvt wrote re: Targeted Radiotherapy for Neuroblastoma with MIBG
on 8 Jan 2011 2:32 AM

LdqcCX  <a href="mjdbapyfzsyk.com/.../a>, [url=http://kzmqzgnaiksn.com/]kzmqzgnaiksn[/url], [link=http://pivaxkdytwed.com/]pivaxkdytwed[/link], http://rycbahhyeirt.com/

Add a Comment

(required)
(optional)
(required)  
Remember Me?
Seten amet diorl oprta ahsellu miokiste porta.

Bean nonumy hendrit mauris phelus porta. Fusce suscipit varius ui. Fusce feugiat malesada odio. Morbi nunc odio, gravida sit cursusnec, luctus aorem. auris phelus porta ae. Fusce suscipit varius ui. Fusce feug.

Read More

There is nothing quite as devastating as hearing that word - neuroblastoma. In seconds your world is turned upside down and your normal life is but a distant memory. You are thrust into a confusing world full of fear. Your child has cancer.

We know. We have been there. The Neuroblastoma Foundation is here for you.

Welcome to our website. It is a place for you to find answers and ask questions. One of the primary goals of the Neuroblastoma Foundation is to ensure that parents, patients and health care professionals find the information they need to make the best treatment decisions possible for children and adults affected by neuroblastoma. There is a vast amount of information throughout the internet, much of which is encapsulated in medical jargon that is so complex that even many medical professionals have difficulty in interpreting its meaning. We are here to help to decipher this information and to make sure you (and your oncologist) understand exactly what it means to you. From treatment decisions to side effects we have parents and experts that have experienced it all and are willing to distill it for you.